Expression of RhoH is a pathogenetic feature of CLL cells because deletion of this protein within the Tcl-1 transgenic mouse model of CLL delays development of the disease by affecting both BCR signaling [132] and cell migration/adhesion [133]. This evidence concerns the gene RHOH and B-cell chronic lymphocytic leukemia.